{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:05:38Z","timestamp":1789477538782,"version":"build-2803163510"},"reference-count":146,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>As the stable and conserved circular non-coding RNAs, circular RNAs (circRNAs) have assumed growing significance in regulating breast cancer immunity and immunotherapy. This review focuses on elucidating the molecular mechanisms through which circRNAs influence the efficacy of breast cancer immunotherapy. Specifically, circRNAs modulate the levels and stability of critical immune checkpoints, including PD-L1 and various cytokines. They achieve this by acting as competing endogenous RNAs (ceRNAs) to sequester miRNAs, functioning as protein scaffolds, and thereby modulating gene expression and tumor immune evasion. Furthermore, circRNAs are capable of facilitating communication between tumor cells and immune cells. In addition, it can be translated into proteins that aid in remodeling the tumor immune microenvironment. These changes may include driving the polarization of immunosuppressive M2-type macrophages, while suppressing the infiltration and functional activity of cytotoxic T cells and natural killer cells. These findings highlight the significant promise of circRNAs serving as novel biomarkers and candidate therapeutic targets. Targeting specific circRNAs is anticipated to emerge as an effective approach for enhancing the efficacy of current immune checkpoint inhibitors, potentially helping to overcome drug resistance encountered in immunotherapy. Furthermore, it offers potential for the development of novel circRNA-based vaccines. Collectively, these advancements pave the way for improving the prognosis of breast cancer immunotherapy and open new avenues for future research and clinical translation.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1923329","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:16:11Z","timestamp":1789474571000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Circular RNAs in tumor immunity and immunotherapy of breast cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Yu","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Wen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca-Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ccr.2012.06.021","article-title":"Snapshot: breast cancer","volume":"22","author":"Polyak","year":"2012","journal-title":"Cancer Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO clinical practice guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0035","article-title":"Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Gradishar","year":"2024","journal-title":"J Natl Compr Cancer Network"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: The St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13045-023-01497-3","article-title":"Recent advances in targeted strategies for triple-negative breast cancer","volume":"16","author":"Zhu","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-24-2172","article-title":"Phase I study of ROR1-specific CAR-T cells in advanced hematopoietic and epithelial Malignancies","volume":"31","author":"Jaeger-Ruckstuhl","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: Biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.783450","article-title":"Breast cancer; discovery of novel diagnostic biomarkers, drug resistance, and therapeutic implications","volume":"9","author":"Afzal","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"10275","DOI":"10.1186\/s13045-020-01027-5","article-title":"Regulation of PD-L1 expression in the tumor microenvironment","volume":"14","author":"Yi","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10549-021-06337-x","article-title":"Breast cancer resistance mechanisms: Challenges to immunotherapy","volume":"190","author":"Hanna","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00539-6","article-title":"Cellular networks controlling T cell persistence in adoptive cell therapy","volume":"21","author":"Chan","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"9396","DOI":"10.1186\/s13045-020-00939-6","article-title":"Dendritic cell biology and its role in tumor immunotherapy","volume":"13","author":"Wang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117753","article-title":"Advancing the next generation of cancer treatment with circular RNAs in CAR-T cell therapy","volume":"181","author":"Huang","year":"2024","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2019.101947","article-title":"Breast cancer vaccines: Heeding the lessons of the past to guide a path forward","volume":"84","author":"Solinas","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00384","article-title":"Oncolytic herpes simplex virus encoding IL12 controls triple-negative breast cancer growth and metastasis","volume":"10","author":"Ghouse","year":"2020","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217865","article-title":"The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): Emerging therapeutic opportunities","volume":"628","author":"Sabit","year":"2025","journal-title":"Cancer Lett"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147517","article-title":"Immunotherapy in breast cancer","volume":"25","author":"Dvir","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40364-021-00318-4","article-title":"Oncolytic viruses for triple negative breast cancer and beyond","volume":"9","author":"Jin","year":"2021","journal-title":"biomark Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41598-018-38385-7","article-title":"Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer","volume":"9","author":"Martin","year":"2019","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02210-0","article-title":"Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: A phase 2 trial","volume":"29","author":"Soliman","year":"2023","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1385571","article-title":"CAR-based immunotherapy for breast cancer: Peculiarities, ongoing investigations, and future strategies","volume":"15","author":"Niu","year":"2024","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.07.036","article-title":"Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches","volume":"349","author":"Davodabadi","year":"2022","journal-title":"J Controlled Release"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-16-3001","article-title":"Breast cancer immunotherapy: Facts and hopes","volume":"24","author":"Emens","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"42623","DOI":"10.1038\/s42003-022-04262-3","article-title":"Mechanisms of circular RNA degradation","volume":"5","author":"Ren","year":"2022","journal-title":"Commun Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-019-1125-9","article-title":"Roles of circRNAs in the tumour microenvironment","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","article-title":"CircRNA in cancer: Fundamental mechanism and clinical potential","volume":"505","author":"Chen","year":"2021","journal-title":"Cancer Lett"},{"key":"B33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-021-01406-7","article-title":"The role of lncRNAs and circRNAs in the PD-1\/PD-L1 pathway in cancer immunotherapy","volume":"20","author":"Jiang","year":"2021","journal-title":"Mol Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90244-s","article-title":"Scrambled exons","volume":"64","author":"Nigro","year":"1991","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1478","article-title":"A 360\u00b0 view of circular RNAs: From biogenesis to functions","volume":"9","author":"Wilusz","year":"2018","journal-title":"WIREs RNA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1101\/gr.202895.115","article-title":"Diverse alternative back-splicing and alternative splicing landscape of circular RNAs","volume":"26","author":"Zhang","year":"2016","journal-title":"Genome Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.molcel.2013.08.017","article-title":"Circular intronic long noncoding RNAs","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.001","article-title":"Complementary sequence-mediated exon circularization","volume":"159","author":"Zhang","year":"2014","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.02.014","article-title":"The RNA binding protein Quaking regulates formation of circRNAs","volume":"160","author":"Conn","year":"2015","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcel.2014.08.019","article-title":"circRNA biogenesis competes with pre-mRNA splicing","volume":"56","author":"Ashwal-Fluss","year":"2014","journal-title":"Mol Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1294","article-title":"Biogenesis, identification, and function of exonic circular RNAs","volume":"6","author":"Chen","year":"2015","journal-title":"Wiley Interdiscip Reviews-Rna"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-08697-2","article-title":"Sphingomyelin regulates the transcriptional machinery in nuclear lipid microdomains","volume":"8","author":"Conte","year":"2025","journal-title":"Commun Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2959","article-title":"Exon-intron circular RNAs regulate transcription in the nucleus","volume":"22","author":"Li","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ymeth.2021.02.020","article-title":"The design and synthesis of circular RNAs","volume":"196","author":"Obi","year":"2021","journal-title":"Methods"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01412-9","article-title":"CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner","volume":"20","author":"Liu","year":"2021","journal-title":"Mol Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.148956","article-title":"A review on circular RNAs in helminth parasites: Insights and potential applications","volume":"333","author":"Giri","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1261\/rna.035667.112","article-title":"Circular RNAs are abundant, conserved, and associated with ALU repeats","volume":"19","author":"Jeck","year":"2013","journal-title":"Rna"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15069331","article-title":"A view of pre-mRNA splicing from RNase R resistant RNAs","volume":"15","author":"Suzuki","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.06.003","article-title":"Circular RNA: A new star of noncoding RNAs","volume":"365","author":"Qu","year":"2015","journal-title":"Cancer Lett"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-024-00806-x","article-title":"The therapeutic potential of circular RNAs","volume":"26","author":"O\u2019Leary","year":"2025","journal-title":"Nat Rev Genet"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003777","article-title":"Cell-type specific features of circular RNA expression","volume":"9","author":"Salzman","year":"2013","journal-title":"PloS Genet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/neuonc\/noaf019","article-title":"CircPRKD3-loaded exosomes concomitantly elicit tumor growth inhibition and glioblastoma microenvironment remodeling via inhibiting STAT3 signaling","volume":"27","author":"Zhang","year":"2025","journal-title":"Neuro-Oncology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0243-y","article-title":"The expanding regulatory mechanisms and cellular functions of circular RNAs","volume":"21","author":"Chen","year":"2020","journal-title":"Nat Rev Mol Cell Bio"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0827-8","article-title":"Circular RNAs function as ceRNAs to regulate and control human cancer progression","volume":"17","author":"Zhong","year":"2018","journal-title":"Mol Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.01.018","article-title":"Review on circular RNAs and new insights into their roles in cancer","volume":"19","author":"Tang","year":"2021","journal-title":"Comput Struct Biotec"},{"key":"B58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.omtn.2019.07.023","article-title":"circFBXW7 inhibits Malignant progression by sponging miR-197-3p and encoding a 185-aa protein in triple-negative breast cancer","volume":"18","author":"Ye","year":"2019","journal-title":"Mol Ther-Nucl Acids"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.05.011","article-title":"circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p\/FOXO3a axis in breast cancer","volume":"27","author":"Sang","year":"2019","journal-title":"Mol Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12967-021-03196-4","article-title":"Analysis and validation of m6A regulatory network: a novel circBACH2\/has-miR-944\/HNRNPC axis in breast cancer progression","volume":"19","author":"Lv","year":"2021","journal-title":"J Transl Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41419-021-03680-1","article-title":"Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637\/Akt1\/beta-catenin (cyclin D1) axis","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.7150\/thno.42174","article-title":"Circular RNA-protein interactions: functions, mechanisms, and identification","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"148019","DOI":"10.1016\/j.gene.2023.148019","article-title":"Interactions between circRNA and protein in breast cancer","volume":"895","author":"Yang","year":"2024","journal-title":"Gene"},{"key":"B65","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13045-022-01345-w","article-title":"CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR","volume":"15","author":"Wang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01567-z","article-title":"Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10","volume":"21","author":"Yang","year":"2022","journal-title":"Mol Cancer"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101126","article-title":"crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer","volume":"77","author":"Zou","year":"2024","journal-title":"Drug Resistance Updates"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-02950-4","article-title":"Novel exosomal circEGFR facilitates triple negative breast cancer autophagy via promoting TFEB nuclear trafficking and modulating miR-224-5p\/ATG13\/ULK1 feedback loop","volume":"43","author":"Song","year":"2024","journal-title":"Oncogene"},{"key":"B69","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12943-020-1135-7","article-title":"Translation and functional roles of circular RNAs in human cancer","volume":"19","author":"Lei","year":"2020","journal-title":"Mol Cancer"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/srep16435","article-title":"Rolling circle translation of circular RNA in living human cells","volume":"5","author":"Abe","year":"2015","journal-title":"Sci Rep"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/srep34985","article-title":"circRNADb: A comprehensive database for human circular RNAs with protein-coding annotations","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.31","article-title":"Extensive translation of circular RNAs driven by N6-methyladenosine","volume":"27","author":"Yang","year":"2017","journal-title":"Cell Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.08.026","article-title":"circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt\/beta-catenin pathway","volume":"30","author":"Li","year":"2022","journal-title":"Mol Ther"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02019-6","article-title":"CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K\/AKT\/mTOR activation","volume":"23","author":"Li","year":"2024","journal-title":"Mol Cancer"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2024.09.016","article-title":"BRCA1 levels and DNA-damage response are controlled by the competitive binding of circHIPK3 or FMRP to the BRCA1 mRNA","volume":"84","author":"Grelloni","year":"2024","journal-title":"Mol Cell"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01246-x","article-title":"CircRNA inhibits DNA damage repair by interacting with host gene","volume":"19","author":"Xu","year":"2020","journal-title":"Mol Cancer"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.223313","article-title":"Connexin 43 maintains tissue polarity and regulates mitotic spindle orientation in the breast epithelium","volume":"132","author":"Bazzoun","year":"2019","journal-title":"J Cell Sci"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1038\/s41598-021-82057-y","article-title":"A risk progression breast epithelial 3D culture model reveals Cx43\/hsa_circ_0077755\/miR-182 as a biomarker axis for heightened risk of breast cancer initiation","volume":"11","author":"Naser Al Deen","year":"2021","journal-title":"Sci Rep"},{"key":"B79","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12943-024-01944-w","article-title":"ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK\/PI3K\/AKT activation in a ceRNA manner","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.58916","article-title":"Circular RNA circBCBM1 promotes breast cancer brain metastasis by modulating miR-125a\/BRD4 axis","volume":"17","author":"Fu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"216907","DOI":"10.1016\/j.canlet.2024.216907","article-title":"circLIFR-007 reduces liver metastasis via promoting hnRNPA1 nuclear export and YAP phosphorylation in breast cancer","volume":"592","author":"Zhang","year":"2024","journal-title":"Cancer Lett"},{"key":"B82","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12943-020-01183-9","article-title":"The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer","volume":"19","author":"Zheng","year":"2020","journal-title":"Mol Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12943-022-01498-9","article-title":"The circROBO1\/KLF5\/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin","volume":"21","author":"Wang","year":"2022","journal-title":"Mol Cancer"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05986-8","article-title":"Cancer-associated fibroblasts facilitate breast cancer progression through exosomal circTBPL1-mediated intercellular communication","volume":"14","author":"Ye","year":"2023","journal-title":"Cell Death Dis"},{"key":"B85","doi-asserted-by":"publisher","first-page":"176943","DOI":"10.1016\/j.ejphar.2024.176943","article-title":"Dihydroartemisinin enhances the radiosensitivity of breast cancer by targeting ferroptosis signaling pathway through hsa_circ_0001610","volume":"983","author":"Zhang","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"116719","DOI":"10.1016\/j.bcp.2024.116719","article-title":"CircDUSP16 mediates the effect of triple-negative breast cancer in pirarubicin via the miR-1224-3p\/TFDP2 axis","volume":"232","author":"Wei","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"102896","DOI":"10.1016\/j.redox.2023.102896","article-title":"The novel \u03b2-TrCP protein isoform hidden in circular RNA confers trastuzumab resistance in HER2-positive breast cancer","volume":"67","author":"Wang","year":"2023","journal-title":"Redox Biol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"107886","DOI":"10.1016\/j.intimp.2021.107886","article-title":"Breast cancer immunotherapy: Current and novel approaches","volume":"98","author":"Barzaman","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","article-title":"Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer","volume":"23","author":"Kundu","year":"2024","journal-title":"Mol Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-024-02082-z","article-title":"Circular RNAs in tumor immunity and immunotherapy","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.617583","article-title":"The potential regulatory roles of circular RNAs in tumor immunology and immunotherapy","volume":"11","author":"Fang","year":"2021","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e005461","DOI":"10.1136\/jitc-2022-005461","article-title":"circ-0000512 inhibits PD-L1 ubiquitination through sponging miR-622\/CMTM6 axis to promote triple-negative breast cancer and immune escape","volume":"11","author":"Dong","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B93","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41420-024-02197-8","article-title":"CircGSK3\u03b2 mediates PD-L1 transcription through miR-338-3p\/PRMT5\/H3K4me3 to promote breast cancer cell immune evasion and tumor progression","volume":"10","author":"Liang","year":"2024","journal-title":"Cell Death Discov"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-021-09237-w","article-title":"Circular RNA hsa_circ_0001598 promotes programmed death-ligand-1-mediated immune escape and trastuzumab resistance via sponging miR-1184 in breast cancer cells","volume":"69","author":"Huang","year":"2021","journal-title":"Immunol Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S411901","article-title":"The circular RNA circFGFR4 facilitates resistance to anti-PD-1 of triple-negative breast cancer by targeting the miR-185-5p\/CXCR4 axis","volume":"15","author":"Wang","year":"2023","journal-title":"Cancer Manag Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13062-023-00397-3","article-title":"Circular RNA hsa_circ_0067842 facilitates tumor metastasis and immune escape in breast cancer through HuR\/CMTM6\/PD-L1 axis","volume":"18","author":"Li","year":"2023","journal-title":"Biol Direct"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e2404628","DOI":"10.1002\/advs.202404628","article-title":"CircCFL1 promotes TNBC stemness and immunoescape via deacetylation\u2010mediated c\u2010Myc deubiquitylation to facilitate mutant TP53 transcription","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s00262-024-03705-6","article-title":"circATAD2 mitigates CD8+ T cells antitumor immune surveillance in breast cancer via IGF2BP3\/m6A\/PD-L1 manner","volume":"73","author":"Zhang","year":"2024","journal-title":"Cancer Immunol Immun"},{"key":"B99","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-023-06834-7","article-title":"Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides","volume":"625","author":"Huang","year":"2023","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","first-page":"108530","DOI":"10.1016\/j.intimp.2022.108530","article-title":"Tumor promoting effect of circ_002172 associates with induced immune escape in breast cancer via the miR-296-5p\/CXCL12 axis","volume":"106","author":"Li","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"106098","DOI":"10.1016\/j.phrs.2022.106098","article-title":"Endoplasmic reticulum stress promotes breast cancer cells to release exosomes circ_0001142 and induces M2 polarization of macrophages to regulate tumor progression","volume":"177","author":"Lu","year":"2022","journal-title":"Pharmacol Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13046-023-02620-5","article-title":"Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-?B-IL-6 axis of tumor-associated macrophages","volume":"42","author":"Zhou","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03627-2","article-title":"Circular RNA CLASP1 modulates the GLI1\/SNAIL axis and enhances macrophage polarization in breast cancer","volume":"44","author":"Zhou","year":"2025","journal-title":"Oncogene"},{"key":"B104","doi-asserted-by":"publisher","first-page":"115333","DOI":"10.1016\/j.colsurfb.2025.115333","article-title":"Exosome circ_0076611-mediated macrophage M2 polarization to improve triple-negative breast cancer metastasis and the intervention of baicalin nano prodrugs","volume":"259","author":"Lan","year":"2026","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01396-1","article-title":"127aa encoded by circSpdyA promotes FA synthesis and NK cell repression in breast cancers","volume":"32","author":"Gao","year":"2024","journal-title":"Cell Death Differ"},{"key":"B106","doi-asserted-by":"publisher","first-page":"217823","DOI":"10.1016\/j.canlet.2025.217823","article-title":"Therapeutic targeting of circTNK2 with nanoparticles restores tamoxifen sensitivity and enhances NK cell-mediated immunity in ER-positive breast cancer","volume":"627","author":"Wu","year":"2025","journal-title":"Cancer Lett"},{"key":"B107","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12935-022-02686-9","article-title":"Circular RNA circWWC3 augments breast cancer progression through promoting M2 macrophage polarization and tumor immune escape via regulating the expression and secretion of IL-4","volume":"22","author":"Zheng","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112408","article-title":"CircPVT1 promotes ER-positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS","volume":"42","author":"Yi","year":"2023","journal-title":"EMBO J"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-026-03819-4","article-title":"circPARPBP promotes cancer stemness and chemoresistance in triple-negative breast cancer through recruiting SRCAP complex to activate CCL20 transcription","volume":"45","author":"Chen","year":"2026","journal-title":"Oncogene"},{"key":"B110","doi-asserted-by":"publisher","first-page":"123885","DOI":"10.1016\/j.lfs.2025.123885","article-title":"CircRHBDD1(4,5)\/CCL2 mRNA interaction promotes breast cancer bone metastasis via bone metastatic niche formation","volume":"383","author":"Li","year":"2025","journal-title":"Life Sci"},{"key":"B111","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27172","article-title":"PD-1\/PD-L1 immune checkpoint: Potential target for cancer therapy","volume":"234","author":"Dermani","year":"2019","journal-title":"J Cell Physiol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway","volume":"21","author":"Ohaegbulam","year":"2015","journal-title":"Trends Mol Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-20-0569","article-title":"The complex integration of T-cell metabolism and immunotherapy","volume":"11","author":"Madden","year":"2021","journal-title":"Cancer Discov"},{"key":"B115","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12943-025-02496-3","article-title":"The enhanced cancer nanovaccine by bidirectionally blocking CXCL12\/CXCR4 axis to inhibit the recurrence and metastasis of triple-negative breast cancer","volume":"24","author":"Liu","year":"2025","journal-title":"Mol Cancer"},{"key":"B116","doi-asserted-by":"publisher","first-page":"20795","DOI":"10.1038\/s41598-023-47816-z","article-title":"Exploring ceRNA networks for key biomarkers in breast cancer subtypes and immune regulation","volume":"13","author":"Shariatmadar Taleghani","year":"2023","journal-title":"Sci Rep"},{"key":"B117","doi-asserted-by":"publisher","first-page":"e3500","DOI":"10.1002\/jgm.3500","article-title":"Comprehensive analysis of the exosomal circRNA-miRNA-mRNA network in breast cancer","volume":"25","author":"Mao","year":"2023","journal-title":"J Gene Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01731","article-title":"Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06945-1","article-title":"Natural killer cell therapies","volume":"626","author":"Vivier","year":"2024","journal-title":"Nature"},{"key":"B121","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","article-title":"NK cell-based cancer immunotherapy: From basic biology to clinical development","volume":"14","author":"Liu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"217825","DOI":"10.1016\/j.canlet.2025.217825","article-title":"Anti-tumor effects on tumor-infiltrating natural killer cells by localized ablative immunotherapy and immune checkpoint inhibitors: An integrated and comparative study using scRNAseq analysis","volume":"627","author":"Liu","year":"2025","journal-title":"Cancer Lett"},{"key":"B123","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Signal Transduct Tar"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10555-024-10226-2","article-title":"TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond","volume":"44","author":"Wu","year":"2024","journal-title":"Cancer Metast Rev"},{"key":"B126","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-021-01474-9","article-title":"CircIL4R activates the PI3K\/AKT signaling pathway via the miR-761\/TRIM29\/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer","volume":"20","author":"Jiang","year":"2021","journal-title":"Mol Cancer"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3580","article-title":"Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract","volume":"17","author":"Xing","year":"2016","journal-title":"Nat Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41467-017-00101-w","article-title":"TRIM29 promotes DNA virus infections by inhibiting innate immune response","volume":"8","author":"Xing","year":"2017","journal-title":"Nat Commun"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701569","article-title":"TRIM29 negatively regulates the Type I IFN production in response to RNA virus","volume":"201","author":"Xing","year":"2018","journal-title":"J Immunol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1038\/s41467-024-44745-x","article-title":"Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.mucimm.2024.10.004","article-title":"TRIM29 controls enteric RNA virus-induced intestinal inflammation by targeting NLRP6 and NLRP9b signaling pathways","volume":"18","author":"Wang","year":"2025","journal-title":"Mucosal Immunol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.04.025","article-title":"ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity","volume":"187","author":"Maxwell","year":"2024","journal-title":"Cell"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2022.06.006","article-title":"Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity","volume":"8","author":"Salvagno","year":"2022","journal-title":"Trends Cancer"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415276","article-title":"Activation of HTR2B suppresses osteosarcoma progression through the STAT1-NLRP3 inflammasome pathway and promotes OASL1+macrophage production to enhance antitumor immunity","volume":"12","author":"Huang","year":"2025","journal-title":"Adv Sci"},{"key":"B135","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41392-023-01561-x","article-title":"Circular RNA vaccine in disease prevention and treatment","volume":"8","author":"Niu","year":"2023","journal-title":"Signal Transduct Tar"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2302191120","article-title":"Circular RNA vaccine induces potent T cell responses","volume":"120","author":"Amaya","year":"2023","journal-title":"P Natl Acad Sci USA"},{"key":"B137","doi-asserted-by":"publisher","first-page":"116373","DOI":"10.1016\/j.bios.2024.116373","article-title":"Simultaneous detection of breast cancer biomarkers circROBO1 and BRCA1 based on a CRISPR-Cas13a\/Cas12a system","volume":"258","author":"Tan","year":"2024","journal-title":"Biosens Bioelectron"},{"key":"B138","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13045-024-01649-z","article-title":"Current and future immunotherapy for breast cancer","volume":"17","author":"Heater","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2024.06.003","article-title":"Next-generation cancer vaccines and emerging immunotherapy combinations","volume":"10","author":"Brandenburg","year":"2024","journal-title":"Trends Cancer"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000003609","article-title":"Immunotherapy and radiotherapy: An effective combination in cancer treatment","volume":"138","author":"Li","year":"2025","journal-title":"Chin Med J"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2017.11.003","article-title":"Breast cancer genomics and immuno-oncological markers to guide immune therapies","volume":"52","author":"Hammerl","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol Cancer"},{"key":"B143","doi-asserted-by":"publisher","first-page":"218690","DOI":"10.1016\/j.canlet.2026.218690","article-title":"Immunotherapy resistance in triple-negative breast cancer: Mechanisms and emerging therapeutic strategies","volume":"658","author":"Zhao","year":"2026","journal-title":"Cancer Lett"},{"key":"B144","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2019.03.046","article-title":"Structure and degradation of circular RNAs regulate PKR activation in innate immunity","volume":"177","author":"Liu","year":"2019","journal-title":"Cell"},{"key":"B145","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.molcel.2017.05.022","article-title":"Sensing self and foreign circular RNAs by intron identity","volume":"67","author":"Chen","year":"2017","journal-title":"Mol Cell"},{"key":"B146","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13046-023-02690-5","article-title":"Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity","volume":"42","author":"Bersani","year":"2023","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1923329\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:16:13Z","timestamp":1789474573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1923329\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":146,"alternative-id":["10.3389\/fimmu.2026.1923329"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1923329","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1923329"}}